Skip to main content
All lobbying filings

CAPITOL HILL CONSULTING GROUP

Lobbying for CLENE NANOMEDICINE · Biopharmaceutical company focused on neurodegenerative diseases,including ALS

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Utah · House · Senate · posted Jul 20, 2026

Official filing document

 Lobbying activity 1
Health Issues

Issues related to accelerated approval.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem